ReviewCancers2025

T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.

Katia Mancuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.